HOYA : Makes Additional Medical Device Venture Investment in InnFocus, Inc., a Glaucoma Device Company

Oct. 5, 2015

HOYA Group announced today that it has participated in a late-stage venture investment in InnFocus, Inc., a Miami-based medical device company developing the InnFocus MicroShunt(TM) for the treatment of open angle glaucoma. This investment follows a strategic relationship established between the two companies in July 2013.

The MicroShunt(TM) is a small tube (less than 1cm in length) used to lower intraocular pressure in patients with open angle glaucoma. It is made of a soft biocompatible material that minimizes damage to tissue and is designed to significantly reduce operation time. InnFocus plans to enter the final phase of clinical trials for the MicroShuntR system to prove it is a safe and effective alternative for the surgical treatment of glaucoma.
'HOYA is very pleased to make this additional investment in InnFocus to further expand our experience and presence in the area of ophthalmology -- we certainly look forward to continuing this strategic relationship with InnFocus as they progress this important device for the potential treatment of glaucoma', said Augustine Yee, Executive Officer, Chief Legal Officer and Head of Corporate Development and Affairs at HOYA Corporation.

CAUTION: INVESTIGATIONAL DEVICE. LIMITED TO INVESTIGATIONAL USE IN THE UNITED STATES.

About InnFocus, Inc.
InnFocus, Inc. is a privately-held company headquartered in Miami, Florida. Company scientists and engineers are global leaders in the development of highly biocompatible biomaterials and medical devices. The InnFocus MicroShunt(TM) is the first of what the company expects to be many, medical devices incorporating these materials in the eye. The InnFocus MicroShunt(TM) was developed in collaboration with the University of Miami, Miller School of Medicine, Bascom Palmer Eye Institute.

About HOYA
Founded in 1941 in Tokyo, Japan, Hoya is a global med-tech company and the leading supplier of innovative high-tech and medical products. Hoya is active in the fields of healthcare and information technology providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses as well as key components for semiconductor devices, LCD panels and HDDs. With over 150 offices and subsidiaries worldwide, Hoya currently employs a multinational workforce of over 34,000 people. For more information, please visit http://www.hoya.com.